1h Free Analyst Time
The Blood Collection Devices Market grew from USD 7.74 billion in 2024 to USD 8.18 billion in 2025. It is expected to continue growing at a CAGR of 5.94%, reaching USD 10.95 billion by 2030.Speak directly to the analyst to clarify any post sales queries you may have.
The blood collection device industry stands at the intersection of medical innovation, stringent regulatory oversight, and evolving healthcare needs. In recent years, heightened focus on patient safety, efficiency, and cost-effectiveness has spurred a wave of technological advancements and material innovations. As healthcare systems worldwide adapt to demographic shifts, emerging infectious diseases, and heightened demand for diagnostics, the role of reliable, scalable blood collection solutions has never been more critical. This executive summary delivers a concise yet comprehensive overview of the market landscape, guiding decision-makers through key trends, regulatory influences, and strategic imperatives. By examining the transformative shifts reshaping device development, assessing the ramifications of new United States tariffs slated for 2025, and distilling insights across product type, technology, material, application, and end-user segments, this document equips stakeholders with actionable intelligence. Furthermore, regional dynamics and competitive benchmarks are explored to illuminate opportunities and challenges across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Ultimately, this summary charted actionable recommendations to steer investment, innovation, and market entry strategies, concluding with a clear call-to-action for organizations seeking to deepen their market understanding and forge lasting growth.
Transformative Shifts Reshaping the Blood Collection Device Landscape
Over the past decade, the blood collection device segment has undergone several disruptive transformations driven by advancements in automation, materials science, and digital integration. Automated blood collection devices have surged in adoption, enhancing throughput and reducing occupational hazards compared to traditional manual collection systems. Innovations in plastic formulations, including biocompatible polymers and antimicrobial additives, have progressively displaced glass-based tubes, responding to sterility requirements and the demand for lightweight, shatter-proof solutions. Moreover, the integration of RFID tagging, barcode scanning, and data analytics into collection workflows has elevated sample traceability and minimized pre-analytical errors. Concurrently, emerging trends in point-of-care diagnostics have cultivated demand for handheld lancets and microcollection devices, fuelling growth in home-use and decentralized testing applications. Regulatory bodies worldwide are harmonizing standards to foster quality and safety, while sustainability considerations are prompting the adoption of recyclable and eco-friendly materials. As a result, manufacturers are pivoting towards modular designs and service-based models, offering device leasing and maintenance packages. These transformative shifts underscore a sector in dynamic evolution-one that balances patient-centricity, operational efficiency, and environmental stewardship.Cumulative Impact of United States Tariffs 2025 on Blood Collection Devices
The imposition of revised United States tariffs effective in 2025 introduces a significant variable for stakeholders in the blood collection device market. Tariff increases on imported medical equipment, including stainless steel needles and specialized plastics used in tubes and bags, have elevated raw material and component costs. Consequently, manufacturers with vertically integrated supply chains are better positioned to absorb these cost pressures, while those reliant on offshore suppliers face margin compression. In response, several players are exploring nearshoring strategies, relocating production closer to end-markets in North America to mitigate tariff impacts and shorten lead times. Additionally, collaborative agreements between U.S. and foreign suppliers are emerging, designed to establish bonded manufacturing zones that defer or reduce tariff liabilities. The new tariff landscape also incentivizes investment in local material recycling and reprocessing initiatives, as recycled stainless steel and polymer feedstocks can circumvent higher duties. Finally, the anticipation of further trade policy shifts is accelerating diversification of import sources, with manufacturers engaging in multi-country supply frameworks to enhance resilience. Taken together, the 2025 tariff adjustments are reshaping cost structures, supply chain architectures, and strategic partnerships across the industry.Key Insights Across Market Segmentation Dimensions
A granular examination of market segmentation reveals critical vectors for innovation and growth. When analyzed by product type, blood bags maintain a foundational role in transfusion services, while the needle segment-encompassing syringe needles and vacuum needles-continues to evolve with safety-engineered features such as retractable tips and integrated shielding. Within blood collection tubes, diversity in additive chemistry underpins distinct diagnostic workflows; EDTA tubes predominate in hematology, Heparin tubes serve clinical chemistry, plasma blood tubes facilitate biobanking applications, and serum tubes cater to immunoassays. The lancet market, too, has expanded to include precision microcollection devices optimized for capillary sampling in remote settings. From a technology perspective, the automated devices segment drives high-volume operations in centralized laboratories, whereas manual devices retain relevance in low-resource environments and point-of-care contexts. Material composition further differentiates offerings: glass tubes exhibit superior chemical resistance but face safety and disposal drawbacks relative to plastic alternatives, while rubber stoppers and stainless steel needles remain critical for seal integrity and performance reliability. Application-based insights highlight diagnostics as the predominant use case, particularly given the surge in population screening and personalized medicine initiatives, whereas therapeutic applications-such as apheresis and autologous transfusion-demand specialized bag configurations and tubing assemblies. End-user analysis shows blood donation centers prioritizing throughput and donor safety, diagnostic centers and pathology laboratories focusing on sample integrity and process optimization, while hospitals and clinics require flexible device portfolios to accommodate diverse patient needs across inpatient and outpatient settings. These segmentation insights furnish a roadmap for product developers and marketers to tailor solutions and align investment priorities.Regional Perspectives Driving Market Behavior
Regional dynamics exert a profound influence on market opportunities and strategic focus. In the Americas, robust healthcare infrastructure, high per-capita diagnostic testing rates, and established reimbursement frameworks underpin steady demand for both manual and automated blood collection solutions. The region’s emphasis on point-of-care diagnostics and home health services is fostering growth in user-friendly lancets and microcollection platforms. Conversely, Europe, Middle East & Africa present a heterogeneous landscape: Western Europe’s stringent regulatory environment and advanced hospital systems drive uptake of safety-engineered needles and barcoded collection tubes, while emerging markets in EMEA focus on cost-effective manual devices and partnerships for capacity expansion. Asia-Pacific exhibits accelerated growth, propelled by large-scale public health initiatives, rising prevalence of chronic diseases, and expanding clinical laboratory networks. Local production hubs in China and India are scaling to meet domestic and export demand, often leveraging competitive labor costs and government incentives. Furthermore, regional trade agreements and free trade zones are reshaping import-export dynamics. These regional insights illuminate the diverse market maturation stages, regulatory climates, and customer priorities that global manufacturers must navigate.Competitive Landscape and Leading Companies Analysis
The competitive landscape features established healthcare conglomerates and specialized medical device companies, each pursuing differentiation through technology leadership, broad product portfolios, or strategic partnerships. Abbott Laboratories leverages its diagnostics expertise to integrate sample collection with on-board analyzers, while AdvaCare Pharma focuses on cost-efficient manual devices for emerging markets. Avanos Medical, Inc. emphasizes safety-engineered catheter and needle systems, and Avantor, Inc. supplies critical raw materials and consumables across the value chain. B. Braun SE distinguishes itself through ecological initiatives in plastic reduction, whereas Becton, Dickinson and Company drives innovation in vacuum-based collection systems. Bio-Rad Laboratories, Inc. enhances its diagnostic reagent ecosystem with customized tube solutions, and Biosigma S.p.A. excels in specialty collection devices for therapeutic applications. Cardinal Health, Inc. and Exelint International, Co. maintain expansive distribution networks, while Fresenius SE & Co. KGaA integrates collection equipment within its extracorporeal therapy platforms. Greiner AG and Haemonetics Corporation by GVS S.p.A. innovate in blood management systems, and ICU Medical, Inc. specializes in closed-system devices to minimize contamination risks. Kawasumi Laboratories America, Inc. and Lasany International cater to niche markets with bespoke lancet and capillary tube assemblies. Medtronic PLC, Merit Medical Systems, Inc., and Nipro Corporation expand through acquisitions and product line extensions, whereas Sarstedt AG & Co. KG, Sekisui Medical Co., Ltd., Siemens Healthineers AG, Terumo Corporation, and Thermo Fisher Scientific Inc. compete on integrated solutions, digital connectivity, and comprehensive service offerings. This constellation of competitors underscores the multifaceted nature of market rivalry, driven by R&D investments, regulatory compliance, and global distribution capabilities.Actionable Recommendations for Industry Leaders
Industry leaders seeking to consolidate their market position should prioritize strategic imperatives that balance innovation, operational resilience, and customer engagement. First, investing in modular automated systems that can seamlessly integrate with laboratory information management systems will address growing demand for data-driven workflows. Second, building localized manufacturing or strategic partnerships in key regions mitigates tariff exposure and enhances supply chain agility. Third, accelerating the development of eco-friendly materials and recyclable components positions companies favorably as sustainability regulations tighten. Fourth, embedding safety-engineered features across all product lines, from syringe needles to lancets, not only fulfills regulatory mandates but also strengthens brand trust among healthcare providers. Fifth, expanding value-added services-such as training, preventive maintenance, and remote monitoring-transforms transactional relationships into long-term collaborations. Lastly, cultivating multidisciplinary partnerships with diagnostic reagent suppliers, software developers, and clinical research organizations creates comprehensive solutions that resonate with end-users prioritizing convenience and reliability. By executing these measures, organizations can drive differentiation, foster loyalty, and secure a competitive edge in an increasingly complex environment.Conclusion: Navigating Future Opportunities
The blood collection device market is poised for sustained transformation as technological innovation, regulatory pressures, and global health priorities converge. Through this summary, we have explored the seismic shifts driven by automation, material science, and digital integration, assessed the implications of forthcoming United States tariffs for 2025, and distilled segmentation, regional, and competitive insights. Organizations that harness these insights can optimize product strategies, streamline supply chains, and enhance customer value. As the market continues to fragment across diverse applications-ranging from high-volume clinical laboratories to decentralized point-of-care settings-the ability to pivot rapidly, anticipate regulatory changes, and forge strategic alliances will determine long-term success. Looking ahead, prioritizing patient safety, environmental sustainability, and data connectivity will be pivotal in unlocking new growth vectors.Market Segmentation & Coverage
This research report categorizes the Blood Collection Devices Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Blood Bags
- Blood Collection Needles
- Syringe Needles
- Vacuum Needles
- Blood Collection Tubes
- EDTA Tubes
- Heparin Tubes
- Plasma Blood Tubes
- Serum Tubes
- Blood Lancets
- Automated Blood Collection Devices
- Manual Blood Collection Devices
- Glass
- Plastic
- Rubber
- Stainless Steel
- Diagnostics
- Therapeutics
- Blood Donation Centers
- Diagnostic Centers & Pathology Laboratory
- Hospitals & Clinics
This research report categorizes the Blood Collection Devices Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Bolivia
- Brazil
- Canada
- Chile
- Colombia
- Costa Rica
- Dominican Republic
- Ecuador
- Guatemala
- Mexico
- Panama
- Paraguay
- Peru
- Puerto Rico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Blood Collection Devices Market to delves into recent significant developments and analyze trends in each of the following companies:
- Abbott Laboratories
- AdvaCare Pharma
- Avanos Medical, Inc.
- Avantor, Inc.
- B. Braun SE
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Biosigma S.p.A.
- Cardinal Health, Inc.
- Exelint International, Co.
- Fresenius SE & Co. KGaA
- Greiner AG
- Haemonetics Corporation by GVS S.p.A.
- ICU Medical, Inc.
- Kawasumi Laboratories America, Inc.
- Lasany International
- Medtronic PLC
- Merit Medical Systems, Inc.
- Nipro Corporation
- Sarstedt AG & Co. KG
- Sekisui Medical Co., Ltd.
- Siemens Healthineers AG
- Terumo Corporation
- Thermo Fisher Scientific Inc.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
6. Market Insights
8. Blood Collection Devices Market, by Product Type
9. Blood Collection Devices Market, by Technology
10. Blood Collection Devices Market, by Material
11. Blood Collection Devices Market, by Application
12. Blood Collection Devices Market, by End Users
13. Americas Blood Collection Devices Market
14. Asia-Pacific Blood Collection Devices Market
15. Europe, Middle East & Africa Blood Collection Devices Market
16. Competitive Landscape
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- AdvaCare Pharma
- Avanos Medical, Inc.
- Avantor, Inc.
- B. Braun SE
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Biosigma S.p.A.
- Cardinal Health, Inc.
- Exelint International, Co.
- Fresenius SE & Co. KGaA
- Greiner AG
- Haemonetics Corporation by GVS S.p.A.
- ICU Medical, Inc.
- Kawasumi Laboratories America, Inc.
- Lasany International
- Medtronic PLC
- Merit Medical Systems, Inc.
- Nipro Corporation
- Sarstedt AG & Co. KG
- Sekisui Medical Co., Ltd.
- Siemens Healthineers AG
- Terumo Corporation
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
